Last reviewed · How we verify
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
This phase I/II trial studies how well dietary and exercise interventions work in reducing side effects in patients with stage I-IIIa breast cancer taking aromatase inhibitors. Anti-inflammatory Mediterranean dietary and bone strengthening exercise interventions may alleviate medication side effects such as joint and bone pain and protectively influence bone mineral density, improve heart functioning, and reduce risk of breast cancer recurrence in breast cancer patients taking aromatase inhibitors.
Details
| Lead sponsor | Jonsson Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 9 |
| Start date | Mon Oct 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Arthralgia
- Postmenopausal
- Prognostic Stage I Breast Cancer AJCC v8
Interventions
- Dietary Intervention
- Exercise Intervention
- Questionnaire Administration
Countries
United States